1. Academic Validation
  2. Musashi1 Contribution to Glioblastoma Development via Regulation of a Network of DNA Replication, Cell Cycle and Division Genes

Musashi1 Contribution to Glioblastoma Development via Regulation of a Network of DNA Replication, Cell Cycle and Division Genes

  • Cancers (Basel). 2021 Mar 24;13(7):1494. doi: 10.3390/cancers13071494.
Mirella Baroni 1 Caihong Yi 1 2 Saket Choudhary 3 Xiufen Lei 1 Adam Kosti 1 4 Denise Grieshober 1 Mitzli Velasco 1 Mei Qiao 1 Suzanne S Burns 1 Patricia R Araujo 1 Talia DeLambre 1 Mi Young Son 5 Michelina Plateroti 6 Marco A R Ferreira 7 Paul Hasty 5 Luiz O F Penalva 1 4
Affiliations

Affiliations

  • 1 Children's Cancer Research Institute, UT Health San Antonio, San Antonio, TX 78229, USA.
  • 2 Third Xiangya Hospital, Central South University, Changsha 410000, China.
  • 3 Computational Biology and Bioinformatics, University of Southern California, Los Angeles, CA 90089, USA.
  • 4 Department of Cell Systems and Anatomy, UT Health San Antonio, San Antonio, TX 78229, USA.
  • 5 Department of Molecular Medicine, Sam and Ann Barshop Institute for Longevity and Aging Studies, UT Health San Antonio, San Antonio, TX 78229, USA.
  • 6 Team: Development, Cancer and Stem Cells, Université de Strasbourg, Inserm, IRFAC/UMR-S1113, FMTS, 67200 Strasbourg, France.
  • 7 Department of Statistics, Virginia Tech, Blacksburg, VA 24060, USA.
Abstract

RNA-binding proteins (RBPs) function as master regulators of gene expression. Alterations in their levels are often observed in tumors with numerous oncogenic RBPs identified in recent years. Musashi1 (Msi1) is an RBP and stem cell gene that controls the balance between self-renewal and differentiation. High Msi1 levels have been observed in multiple tumors including glioblastoma and are often associated with poor patient outcomes and tumor growth. A comprehensive genomic analysis identified a network of cell cycle/division and DNA replication genes and established these processes as Msi1's core regulatory functions in glioblastoma. Msi1 controls this gene network via two mechanisms: direct interaction and indirect regulation mediated by the transcription factors E2F2 and E2F8. Moreover, glioblastoma lines with Msi1 knockout (KO) displayed increased sensitivity to cell cycle and DNA replication inhibitors. Our results suggest that a drug combination strategy (Msi1 + cell cycle/DNA replication inhibitors) could be a viable route to treat glioblastoma.

Keywords

DNA replication; E2F2; E2F8; Musashi1; cell cycle; cell division; glioblastoma.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-50767
    99.94%, CDK4/6 Inhibitor
    CDK